Citadel Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,550
| Closed | -$79.9K | – | 6457 |
|
|
2025
Q1 | $79.9K | Buy |
+26,550
| New | +$79.9K | ﹤0.01% | 5224 |
|
|
2024
Q4 | – | Sell |
-10,114
| Closed | -$37K | – | 6411 |
|
|
2024
Q3 | $37K | Buy |
+10,114
| New | +$37K | ﹤0.01% | 5193 |
|
|
2024
Q1 | – | Sell |
-10,287
| Closed | -$49.1K | – | 6521 |
|
|
2023
Q4 | $49.1K | Buy |
+10,287
| New | +$49.1K | ﹤0.01% | 5124 |
|
|
2023
Q2 | – | Sell |
-1,570
| Closed | -$47.2K | – | 6171 |
|
|
2023
Q1 | $47.2K | Buy |
+1,570
| New | +$47.2K | ﹤0.01% | 5180 |
|
|
2022
Q3 | – | Sell |
-129
| Closed | -$22K | – | 6327 |
|
|
2022
Q2 | $22K | Buy |
+129
| New | +$22K | ﹤0.01% | 5691 |
|
|
2021
Q3 | – | Sell |
-59
| Closed | -$77K | – | 6768 |
|
|
2021
Q2 | $77K | Buy |
59
+3
| +5% | +$3.92K | ﹤0.01% | 6067 |
|
|
2021
Q1 | $100K | Buy |
+56
| New | +$100K | ﹤0.01% | 5851 |
|
|
2019
Q1 | – | Sell |
-9
| Closed | -$22K | – | 4823 |
|
|
2018
Q4 | $22K | Buy |
9
+2
| +29% | +$4.89K | ﹤0.01% | 4238 |
|
|
2018
Q3 | $11K | Buy |
7
+2
| +40% | +$3.14K | ﹤0.01% | 4201 |
|
|
2018
Q2 | $14K | Sell |
5
-5
| -50% | -$14K | ﹤0.01% | 4088 |
|
|
2018
Q1 | $22K | Buy |
10
+4
| +67% | +$8.8K | ﹤0.01% | 3858 |
|
|
2017
Q4 | $34K | Buy |
+6
| New | +$34K | ﹤0.01% | 3705 |
|